Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 33 for mesothelioma

Edit search filters
  1. A Study of HFB200301 in Adult Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. In-home Versus In-Clinic Subcutaneous Nivolumab Administration through Connected and Remote Cancer CARE Beyond Walls

    Jacksonville, FL

  3. Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Understanding the Challenges, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials in Minority Patient Populations

    Jacksonville, FL, Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study to Evaluate Exercise for Cancer Patients at Risk of Falling

    Rochester, MN

  6. A Study of Staging Procedures to Diagnose Malignant Pleural Mesothelioma

    Rochester, MN

  7. A Study of Response Rate and Survival from Combined Chemotherapy, Surgery and Radiation Therapy for Patients with Malignant Mesothelioma

    Rochester, MN

  8. Tumor Heterogeneity of the Tumor Microenvironment in Malignant Pleural Mesothelioma (MPM)

    Rochester, MN

  9. A Study of Performing Surgery for Resectable Malignant Pleural Mesothelioma After Radiation Therapy

    Rochester, MN

  10. Determining the Special Gene Expressions in Patients with Lung Cancer or Mesothelioma

    Rochester, MN

.

Mayo Clinic Footer